Peripheral blood progenitor cell mobilization and collection in 42 patients with primary systemic amyloidosis

Transfusion

Volumn 45, Issue 11, 2005, Pages 1729-1734

  Perotti, Cesare ^a   Del Fante, Claudia ^a   Viarengo, Gianluca ^a   Perlini, Stefano ^a   Vezzoli, Monia ^a   Rodi, Giuseppe ^a   Palo, Alessandra ^a   Bergamaschi, Paola ^a   Salvaneschi, Laura ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; NORADRENALIN;

ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CD34 SELECTION; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FLOW CYTOMETRY; HEART AMYLOIDOSIS; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN TISSUE; HYPOTENSION; KIDNEY AMYLOIDOSIS; LEUKOCYTE COUNT; MALE; MORBIDITY; MORTALITY; NAUSEA; PERIPHERAL BLOOD STEM CELL; STEM CELL MOBILIZATION; SWEATING; VOMITING; AMYLOIDOSIS; BLOOD; CARDIOMYOPATHY; HOSPITALIZATION; INCIDENCE; KIDNEY DISEASE; LABORATORY DIAGNOSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT CARE;

ADULT; AGED; AMYLOIDOSIS; CARDIOMYOPATHIES; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; HYPOTENSION; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED; PATIENT CARE TEAM; SEVERITY OF ILLNESS INDEX; SPECIMEN HANDLING;

EID: 33644663013     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.00597.x     Document Type: Article

References (25)

1. Merlini G Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003 349 : 583 96.
2. Merlini G Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med 2004 255 : 159 78.
3. Comenzo RL Gertz AM. Autologous stem cell transplantation for primary systemic amyloidosis. Blood 2002 99 : 4276 82.
4. Saba N Sutton DM Ross HJ Siu S, et al. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant 1999 24 : 853 5.
5. Sanchorawala V Wright DG Seldin DC Dember LM, et al. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant 2001 28 : 637 42.
6. Comenzo RL. Hematopoietic cell transplantation for primary systemic amyloidosis: what have we learned. Leuk Lymphoma 2000 37 : 245 58.
7. Dispenzieri A Kyle RA Lacy MQ, et al. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood 2004 103 : 3960 3.
8. Seldin DC Anderson JJ Sanchorawala V Malek K, et al. Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood 2004 104 : 1888 93.
9. Comenzo RL Vosburgh E Falk RH Sanchorawala V, et al. Dose-intensive melphalan with blood stem-cell support for the tratment of AL amyloidosis: survival and responses in 25 patients. Blood 1998 91 : 3662 70.
10. Gillmore JD Apperley JF Craddock C. High dose melphalan and stem cell rescue for AL amyloidosis. In: Kyle RA Gertz MA, editors. Amyloid and amyloidosis. Pearl River (NY) : Parthenon Publishing; 1999. p. 1 02 4.
11. Moreau P Leblond V Bourquelot P, et al. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. Br J Haematol 1998 101 : 766 9.
12. Schulenburg A Kalhs P Oberhuber G, et al. Gastrointestinal perforation early after peripheral blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplant 1998 22 : 293 5.
13. Kumar S Dispenzieri A Lacy MQ, et al. High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis. Bone Marrow Transplant 2001 28 : 381 5.
14. Zenhausern R Tobler A Leoncini L, et al. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 2000 79 : 523 6.
15. Comenzo RL Sanchorawala V Fisher C, et al. Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis. Br J Haematol 1999 104 : 553 9.
16. Palladini G Perfetti V Obici L, et al. The association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis ineligible for stem cell transplantation. Blood 2004 103 : 2936 8.
17. Bernardi L Passino C Porta C, et al. Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension? Heart 2002 88 : 615 21.
18. Palladini G Campana C Klersy C, et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 2003 107 : 2440 5.
19. Dubrey SW Cha K Anderson J, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. Q J Med 1998 91 : 141 57.
20. Palladini G Malamani G Co F et al. G. Holter monitoring in AL amyloidosis: prognostic implications. Pacing Clin Electrophysiol 2001 24 : 1228 33.
21. Kyle RA Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995 32 : 45 59.
22. Brando B Barnett D Janossy G, et al. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. Cytometry 2000 42 : 327 46.
23. Gertz MA Lacy MQ Gastineau DA, et al. Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL). Bone Marrow Transplant 2000 26 : 963 9.
24. Comenzo RL. Autologous hematopoietic cell transplantation for AL amyloidosis. In: Forman SJ Blume KG Thomas ED, editors. Hematopoietic cell transplantation. 2nd ed. New York (NY) : Blackwell Scientific; 1999. p. 1 014 28.
25. Attal M Harrousseau JL Facon T, et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003 26 : 2495 502.